These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 20815793)
21. Design of experiments utilization to map the processing capabilities of a micro-spray dryer: particle design and throughput optimization in support of drug discovery. Ormes JD; Zhang D; Chen AM; Hou S; Krueger D; Nelson T; Templeton A Pharm Dev Technol; 2013 Feb; 18(1):121-9. PubMed ID: 22414114 [TBL] [Abstract][Full Text] [Related]
22. Effects of automated external lubrication on tablet properties and the stability of eprazinone hydrochloride. Yamamura T; Ohta T; Taira T; Ogawa Y; Sakai Y; Moribe K; Yamamoto K Int J Pharm; 2009 Mar; 370(1-2):1-7. PubMed ID: 19059327 [TBL] [Abstract][Full Text] [Related]
23. The effects of spray drying, HPMCAS grade, and compression speed on the compaction properties of itraconazole-HPMCAS spray dried dispersions. Honick M; Das S; Hoag SW; Muller FX; Alayoubi A; Feng X; Zidan A; Ashraf M; Polli JE Eur J Pharm Sci; 2020 Dec; 155():105556. PubMed ID: 32946956 [TBL] [Abstract][Full Text] [Related]
24. Modeling of a roller-compaction process using neural networks and genetic algorithms. Turkoglu M; Aydin I; Murray M; Sakr A Eur J Pharm Biopharm; 1999 Nov; 48(3):239-45. PubMed ID: 10612035 [TBL] [Abstract][Full Text] [Related]
25. Frosta: a new technology for making fast-melting tablets. Jeong SH; Fu Y; Park K Expert Opin Drug Deliv; 2005 Nov; 2(6):1107-16. PubMed ID: 16296813 [TBL] [Abstract][Full Text] [Related]
26. Considerations about the theoretically expected crushing strength of tablets from binary powder mixtures: double layer tablets versus arithmetic additivity rule. Belda PM; Mielck JB Eur J Pharm Biopharm; 2006 Nov; 64(3):343-50. PubMed ID: 16914296 [TBL] [Abstract][Full Text] [Related]
27. Multivariate analysis of relationships between material properties, process parameters and tablet tensile strength for alpha-lactose monohydrates. Haware RV; Tho I; Bauer-Brandl A Eur J Pharm Biopharm; 2009 Nov; 73(3):424-31. PubMed ID: 19698784 [TBL] [Abstract][Full Text] [Related]
28. Eudragit E as excipient for production of granules and tablets from Phyllanthus niruri L spray-dried extract. Pereira de Souza T; Martínez-Pacheco R; Gómez-Amoza JL; Petrovick PR AAPS PharmSciTech; 2007 Apr; 8(2):Article 34. PubMed ID: 17622112 [TBL] [Abstract][Full Text] [Related]
29. Optimization of a formulation containing viable lactic acid bacteria. Stadler M; Viernstein H Int J Pharm; 2003 Apr; 256(1-2):117-22. PubMed ID: 12695017 [TBL] [Abstract][Full Text] [Related]
30. Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers. II. Effect of HPMC with different degrees of methoxy/hydroxypropyl substitution. Escudero JJ; Ferrero C; Jiménez-Castellanos MR Int J Pharm; 2010 Mar; 387(1-2):56-64. PubMed ID: 19969052 [TBL] [Abstract][Full Text] [Related]
31. Absolute molecular weight determination of hypromellose acetate succinate by size exclusion chromatography: use of a multi angle laser light scattering detector and a mixed solvent. Chen R; Ilasi N; Sekulic SS J Pharm Biomed Anal; 2011 Dec; 56(4):743-8. PubMed ID: 21840663 [TBL] [Abstract][Full Text] [Related]
32. Zero-order release of aspirin, theophylline and atenolol in water from novel methylcellulose glutarate matrix tablets. Khairuzzaman A; Ahmed SU; Savva M; Patel NK Int J Pharm; 2006 Aug; 318(1-2):15-21. PubMed ID: 16621361 [TBL] [Abstract][Full Text] [Related]
33. The use of hypromellose in oral drug delivery. Li CL; Martini LG; Ford JL; Roberts M J Pharm Pharmacol; 2005 May; 57(5):533-46. PubMed ID: 15901342 [TBL] [Abstract][Full Text] [Related]
34. Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets. Viridén A; Wittgren B; Larsson A Eur J Pharm Sci; 2009 Feb; 36(2-3):297-309. PubMed ID: 19038336 [TBL] [Abstract][Full Text] [Related]
35. Real-time in-die compaction monitoring of dry-coated tablets. Liu J; Stephens JD; Kowalczyk BR; Cetinkaya C Int J Pharm; 2011 Jul; 414(1-2):171-8. PubMed ID: 21605647 [TBL] [Abstract][Full Text] [Related]
37. Influence of sodium dodecyl sulfate on swelling, erosion and release behavior of HPMC matrix tablets containing a poorly water-soluble drug. Zeng A; Yuan B; Fu Q; Wang C; Zhao G Pharm Dev Technol; 2009; 14(5):499-505. PubMed ID: 19743948 [TBL] [Abstract][Full Text] [Related]
38. Non-destructive determination of the coating film thickness by X-ray powder diffractometry and correlation with the dissolution behavior of film-coated tablets. Yamada H; Terada K; Suryanarayanan R J Pharm Biomed Anal; 2010 Mar; 51(4):952-7. PubMed ID: 19945243 [TBL] [Abstract][Full Text] [Related]
39. A material-sparing method for simultaneous determination of true density and powder compaction properties--aspartame as an example. Sun CC Int J Pharm; 2006 Dec; 326(1-2):94-9. PubMed ID: 16926076 [TBL] [Abstract][Full Text] [Related]
40. Development of a Control Strategy for Benzene Impurity in HPMCAS-Stabilized Spray-Dried Dispersion Drug Products Using a Science-Based and Risk-Based Approach. Yue H; Nicholson SJ; Young JD; Hsieh D; Ketner RJ; Hall RG; Sackett J; Banks EC; Castoro JA; Randazzo ME Pharm Res; 2015 Aug; 32(8):2636-48. PubMed ID: 25724159 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]